Annual EBIT
-$60.19 M
+$13.61 M+18.44%
31 December 2023
Summary:
AC Immune SA annual earnings before interest & taxes is currently -$60.19 million, with the most recent change of +$13.61 million (+18.44%) on 31 December 2023. During the last 3 years, it has risen by +$5.66 million (+8.60%). ACIU annual EBIT is now -226.24% below its all-time high of $49.38 million.ACIU EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly EBIT
$6.40 M
+$31.53 M+125.48%
01 September 2024
Summary:
AC Immune SA quarterly earnings before interest & taxes is currently $6.40 million, with the most recent change of +$31.53 million (+125.48%) on 01 September 2024. Over the past year, it has increased by +$23.52 million (+137.41%). ACIU quarterly EBIT is now -90.14% below its all-time high of $64.90 million, reached on 31 March 2019.ACIU Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM EBIT
-$44.45 M
+$23.52 M+34.60%
01 September 2024
Summary:
AC Immune SA TTM earnings before interest & taxes is currently -$44.45 million, with the most recent change of +$23.52 million (+34.60%) on 01 September 2024. Over the past year, it has increased by +$29.65 million (+40.01%). ACIU TTM EBIT is now -184.40% below its all-time high of $52.66 million, reached on 30 September 2019.ACIU TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ACIU EBIT Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +18.4% | +137.4% | +40.0% |
| 3 y3 years | +8.6% | +137.3% | +42.9% |
| 5 y5 years | -16.3% | -65.5% | -184.4% |
ACIU EBIT High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +24.0% | at high | +125.5% | at high | +45.1% |
| 5 y | 5 years | -226.2% | +24.0% | -65.5% | +125.5% | -184.4% | +45.4% |
| alltime | all time | -226.2% | +24.0% | -90.1% | +125.5% | -184.4% | +45.4% |
AC Immune SA EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $6.40 M(-125.5%) | -$44.45 M(-34.6%) |
| June 2024 | - | -$25.13 M(+23.2%) | -$67.96 M(+10.5%) |
| Mar 2024 | - | -$20.40 M(+283.2%) | -$61.53 M(+2.7%) |
| Dec 2023 | -$60.19 M(-18.4%) | -$5.32 M(-68.9%) | -$59.93 M(-19.1%) |
| Sept 2023 | - | -$17.11 M(-8.5%) | -$74.10 M(+4.5%) |
| June 2023 | - | -$18.69 M(-0.6%) | -$70.89 M(-2.1%) |
| Mar 2023 | - | -$18.80 M(-3.5%) | -$72.42 M(-1.9%) |
| Dec 2022 | -$73.80 M(-6.9%) | -$19.48 M(+40.1%) | -$73.85 M(-4.4%) |
| Sept 2022 | - | -$13.91 M(-31.2%) | -$77.26 M(-4.0%) |
| June 2022 | - | -$20.22 M(-0.1%) | -$80.49 M(-0.6%) |
| Mar 2022 | - | -$20.23 M(-11.6%) | -$80.98 M(+2.2%) |
| Dec 2021 | -$79.23 M(+20.3%) | -$22.89 M(+33.5%) | -$79.22 M(+1.7%) |
| Sept 2021 | - | -$17.14 M(-17.3%) | -$77.88 M(-4.3%) |
| June 2021 | - | -$20.72 M(+12.1%) | -$81.34 M(+5.8%) |
| Mar 2021 | - | -$18.47 M(-14.3%) | -$76.90 M(+16.0%) |
| Dec 2020 | -$65.85 M(-238.1%) | -$21.55 M(+4.6%) | -$66.31 M(+3.3%) |
| Sept 2020 | - | -$20.60 M(+26.6%) | -$64.17 M(+156.8%) |
| June 2020 | - | -$16.27 M(+106.3%) | -$24.99 M(-0.3%) |
| Mar 2020 | - | -$7.89 M(-59.3%) | -$25.07 M(-152.5%) |
| Dec 2019 | $47.68 M | -$19.40 M(-204.5%) | $47.73 M(-9.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2019 | - | $18.57 M(-213.6%) | $52.66 M(+158.4%) |
| June 2019 | - | -$16.35 M(-125.2%) | $20.38 M(-19.9%) |
| Mar 2019 | - | $64.90 M(-548.6%) | $25.44 M(-149.2%) |
| Dec 2018 | -$51.74 M(+94.1%) | -$14.47 M(+5.6%) | -$51.70 M(+56.9%) |
| Sept 2018 | - | -$13.71 M(+21.4%) | -$32.95 M(+16.2%) |
| June 2018 | - | -$11.29 M(-7.7%) | -$28.37 M(-3.9%) |
| Mar 2018 | - | -$12.23 M(-385.9%) | -$29.52 M(+10.6%) |
| Dec 2017 | -$26.66 M(+270.5%) | $4.28 M(-146.9%) | -$26.70 M(-25.3%) |
| Sept 2017 | - | -$9.12 M(-26.6%) | -$35.73 M(-0.6%) |
| June 2017 | - | -$12.44 M(+32.1%) | -$35.94 M(+253.4%) |
| Mar 2017 | - | -$9.41 M(+97.9%) | -$10.17 M(+54.6%) |
| Dec 2016 | -$7.20 M(-134.2%) | -$4.76 M(-49.0%) | -$6.58 M(-11.8%) |
| Sept 2016 | - | -$9.33 M(-170.0%) | -$7.46 M(-132.8%) |
| June 2016 | - | $13.33 M(-329.0%) | $22.76 M(+22.8%) |
| Mar 2016 | - | -$5.82 M(+3.2%) | $18.54 M(-12.8%) |
| Dec 2015 | $21.06 M(+79.1%) | -$5.64 M(-127.0%) | $21.25 M(-21.0%) |
| Sept 2015 | - | $20.89 M(+129.2%) | $26.89 M(+348.1%) |
| June 2015 | - | $9.11 M(-392.8%) | $6.00 M(-292.8%) |
| Mar 2015 | - | -$3.11 M | -$3.11 M |
| Dec 2014 | $11.76 M | - | - |
FAQ
- What is AC Immune SA annual earnings before interest & taxes?
- What is the all time high annual EBIT for AC Immune SA?
- What is AC Immune SA annual EBIT year-on-year change?
- What is AC Immune SA quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for AC Immune SA?
- What is AC Immune SA quarterly EBIT year-on-year change?
- What is AC Immune SA TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for AC Immune SA?
- What is AC Immune SA TTM EBIT year-on-year change?
What is AC Immune SA annual earnings before interest & taxes?
The current annual EBIT of ACIU is -$60.19 M
What is the all time high annual EBIT for AC Immune SA?
AC Immune SA all-time high annual earnings before interest & taxes is $49.38 M
What is AC Immune SA annual EBIT year-on-year change?
Over the past year, ACIU annual earnings before interest & taxes has changed by +$13.61 M (+18.44%)
What is AC Immune SA quarterly earnings before interest & taxes?
The current quarterly EBIT of ACIU is $6.40 M
What is the all time high quarterly EBIT for AC Immune SA?
AC Immune SA all-time high quarterly earnings before interest & taxes is $64.90 M
What is AC Immune SA quarterly EBIT year-on-year change?
Over the past year, ACIU quarterly earnings before interest & taxes has changed by +$23.52 M (+137.41%)
What is AC Immune SA TTM earnings before interest & taxes?
The current TTM EBIT of ACIU is -$44.45 M
What is the all time high TTM EBIT for AC Immune SA?
AC Immune SA all-time high TTM earnings before interest & taxes is $52.66 M
What is AC Immune SA TTM EBIT year-on-year change?
Over the past year, ACIU TTM earnings before interest & taxes has changed by +$29.65 M (+40.01%)